Astec LifeSciences Limited

Chemicals · Fertilizers & Agrochemicals

NSE: ASTEC BSE: 533138
₹722.75
▲ 26.50 (3.81%)
Sept. 30, 2026 · NSE · nse_bhavcopy
Quality
20/100
Weak
Valuation
38/100
Fairly Valued
Momentum
35/100
Neutral

QVM read Mixed signals Quality Weak, Valuation Fairly Valued, Momentum Neutral

Tradinity's own scoring, not a copy of any third party's -- see the Key Metrics section for the real ratios behind each number.

Key Metrics

Market Capitalization
₹1,610 Cr
PE (TTM)
Data unavailable.
Price to Book
4.1
PEG (TTM)
Data unavailable (needs 8 quarters of EPS).
Institutions holding %
3.34%
FII + DII, latest filed period
Piotroski Score
5
Relative return vs Nifty50, qtr %
6.8
Relative return vs Sector, qtr %
11.5
Free Cash Flow
₹-86 Cr
as of March 31, 2026
Industry median ₹1 Cr (51 companies)
EPS Growth (YoY)
50.12%
as of June 30, 2026
Industry median 11.34% (47 companies)
Net Profit Growth (TTM)
30.28%
as of June 30, 2026
Industry median 13.05% (46 companies)
Operating Revenue Growth (TTM)
9.33%
as of June 30, 2026
Industry median 4.42% (46 companies)
Profit Growth (YoY)
61.09%
as of Dec. 31, 2025
Industry median 11.58% (46 companies)
Revenue Growth (YoY)
-8.25%
as of June 30, 2026
Industry median -1.79% (46 companies)
Current Ratio
0.89
as of March 31, 2026
Industry median 1.55 (49 companies)
Debt to Equity
1.15
as of March 31, 2026
Industry median 0.32 (48 companies)
Interest Coverage
-1.14
as of June 30, 2026
Industry median 4.24 (48 companies)
Net Margin
-12.60%
as of Dec. 31, 2025
Industry median 6.16% (48 companies)
Operating Margin (EBIT)
-13.21%
as of June 30, 2026
Industry median 9.73% (48 companies)
Operating Margin (TTM)
-8.09%
as of June 30, 2026
Industry median 8.58% (48 companies)
Return on Assets
-8.59%
as of March 31, 2026
Industry median 4.14% (47 companies)
Return on Capital Employed
-10.51%
as of March 31, 2026
Industry median 11.17% (47 companies)
Return on Equity
-20.69%
as of March 31, 2026
Industry median 7.44% (47 companies)

Investment checklist

Tradinity's own yes/no questions with the rule stated beside each. “Items without enough data are left out, never counted as a No, and the totals count only answered questions. A summary of numbers on this page, not advice.

Financials

1 of 7 met
  • No Revenue is higher than a year earlier in each of the last 4 quarters
  • No Quality score is Strong (70 or more)
  • No Piotroski F-score is 7 or more (score 5)
  • No Debt to equity is below 0.5 (1.15)
  • No Return on equity is 15% or more (-20.7%)
  • Yes Net cash flow for the latest year is positive
  • No Cash from operations is higher than the year before

Ownership

2 of 4 met
  • No FII/FPI or DII holding rose in the latest quarter
  • No Promoter holding rose or was unchanged in the latest quarter
  • Yes Promoter pledge is 5% of their holding or less and not rising (0.0% pledged)
  • Yes Insiders have not sold in the past 3 months (no open-market sale filed in the last 3 months)

Peer comparison

2 of 3 met
  • Yes 1-year return beats the industry median
  • No Revenue growth beats the industry median
  • Yes Profit growth beats the industry median

Value and momentum

1 of 5 met
  • No Valuation score is Undervalued (70 or more)
  • No Momentum score is Bullish (70 or more)
  • No Price is above the 5, 10 and 20 day averages
  • Yes Price is above the 50, 100 and 200 day averages
  • No Latest candle has a bullish shape (hammer, dragonfly doji, white marubozu)

Price

Download CSV

PE/EPS use each quarter's real filed EPS only from 45 days after quarter-end (no look-ahead) against the raw close of the day. Price-to-book isn't a mode here: the feed has no dated share count, so there's no real history to chart.

RSI (14) (same adjusted close series as the price chart above)

MACD (12, 26, 9) (same adjusted close series as the price chart above)

Relative Returns (vs NIFTY 50)

Prices adjusted for splits and bonuses. * = a corporate action affecting this date could not be parsed and is not reflected.

Price range

Day return
3.8%
Low 699.0000 · High 787.8000
1W return
-4.6%
Low 686.8000 · High 787.8000
1M return
28.9%
Low 540.0000 · High 825.9500
52W return
-9.9%
Low 513.4000 · High 941.7500
Lifetime High ₹2250.7500 (Oct. 20, 2022)
Lifetime Low ₹15.0000 (Aug. 5, 2013)

Full price history and technicals →

EMA & SMA

Bullish6
Bearish0
5D
720.3
10D
717.6
20D
695.9
50D
671.7
100D
670.1
200D
667.4

Delivery and volume

Day avg. delivery
35.0%
Week avg. delivery
11.3%
Month avg. delivery
10.9%

Week = 5 sessions, Month = 22 sessions ending the latest trading day — the same combined NSE+BSE delivery data as the table below, just summed.

Resistance and support

736.52
Pivot
First resistance774.03
Second resistance825.32
Third resistance862.83
First support685.23
Second support647.72
Third support596.43
Day RSI55.4
Day MFI79.6
Day MACD27.51
Day MACD signal28.05

Beta

1M-0.89
3M-0.44
1Y0.84
3Y0.68

Price change analysis

↑ 28.9%
Over 1 Month
LowHigh
540.00825.95
↑ 1.3%
Over 3 Months
LowHigh
540.00825.95
↑ 29.6%
Over 6 Months
LowHigh
534.00850.00
↓ -9.9%
Over 1 Year
LowHigh
513.40941.75
Legend Positive indicator Neutral indicator Negative indicator

Buy/Sell Zone

View Buy/Sell Zone →

Data unavailable (needs at least 2 historical quarters with both a filed EPS and a matching trading day).

Revenue (June 30, 2026)
₹84 Cr
Net profit (June 30, 2026)
₹-19 Cr
Basic EPS (June 30, 2026)
₹-8.4100

Ranks #18 of 44 in Fertilizers & Agrochemicals by market cap -- full peer table on the Financials page.

Shareholding pattern / Ownership

Shareholding summary

Jun 2026
  • Promoter71.96%
  • Mutual funds3.02%
  • FII/FPI0.01%
  • Other DII0.31%
  • Public24.70%

Largest holders

NameCategoryShares %Shares
GODREJ AGROVET LIMTEDPromoter67.0300%14935245
NIPPON LIFE INDIA TRUSTEE LTD-A/C NIPPON INDIA SMALL CAP FUNDPublic2.3600%526867
NADIR BURJOR GODREJPromoter1.8200%404782
ASHOK VISHWANATH HIREMATHPromoter1.3100%290802
AJAY KUMAR AGGARWALPublic1.0500%234306

As of June 30, 2026. Only holders the filing discloses individually.

Historical promoter holding

Promoters holdings decreased from 71.97% to 71.96% in Jun 2026 qtr

Historical fii holding

FII/FPI holdings decreased from 0.02% to 0.01% in Jun 2026 qtr

Historical mutual fund holding

Mutual funds holdings were unchanged at 3.02% in Jun 2026 qtr

2 mutual fund schemes also hold this stock.

All shareholding details →

Latest insider trades

FiledPersonCategoryTypeQuantityValue
31 Jul 2025 GODREJ AGROVET LIMITED Promoter Buy 0 ₹0
2 Jan 2025 Nisaba Godrej Promoter group Buy 0 ₹0
2 Jan 2025 Nadir Godrej Promoter group Buy 0 ₹0
2 Jan 2025 Pirojsha Godrej Promoter group Buy 0 ₹0
2 Jan 2025 Tanya Dubash Promoter group Buy 0 ₹0
7 Jun 2023 Balram Singh Yadav Director Sell 0 ₹0
12 Aug 2022 GODREJ AGROVET LIMITED Promoter Buy 0 ₹0
12 Aug 2022 GODREJ AGROVET LIMITED Promoter Buy 0 ₹0
4 Aug 2022 GODREJ AGROVET LIMITED Promoter Buy 0 ₹0
4 Aug 2022 GODREJ AGROVET LIMITED Promoter Buy 0 ₹0

All insider and SAST disclosures →

DateClientDealActionQuantityPriceExchange
9 Sep 2026 QE SECURITIES LLP Bulk Sell 180,734 750.4400 NSE
9 Sep 2026 QE SECURITIES LLP Bulk Buy 180,108 754.5700 NSE
9 Sep 2026 NK SECURITIES RESEARCH PRIVATE LIMITED Bulk Sell 172,956 752.7000 NSE
9 Sep 2026 NK SECURITIES RESEARCH PRIVATE LIMITED Bulk Buy 172,956 752.3900 NSE
9 Sep 2026 MICROCURVES TRADING PRIVATE LIMITED Bulk Sell 255,931 753.1000 NSE
9 Sep 2026 MICROCURVES TRADING PRIVATE LIMITED Bulk Buy 255,931 752.6000 NSE
9 Sep 2026 JUNOMONETA FINSOL PRIVATE LIMITED Bulk Sell 196,601 754.7100 NSE
9 Sep 2026 JUNOMONETA FINSOL PRIVATE LIMITED Bulk Buy 193,946 754.5000 NSE
9 Sep 2026 ALPHAGREP SECURITIES PRIVATE LIMITED Bulk Buy 190,586 749.2700 NSE
9 Sep 2026 ALPHAGREP SECURITIES PRIVATE LIMITED Bulk Sell 190,586 749.6800 NSE

All bulk and block deals →

Ex-dateSubjectPer share (₹)Record date
21 Jul 2023 Annual General Meeting/Dividend - Rs 1.50 Per Share 1.5000 —
19 Jul 2022 Annual General Meeting/Dividend - Rs 1.50 Per Share 1.5000 —
22 Jul 2021 Annual General Meeting/Dividend - Rs 1.50 Per Share 1.5000 —
16 Jul 2020 Annual General Meeting/Dividend - Rs 1.50 Per Share 1.5000 —
18 Jul 2019 Annual General Meeting/ Dividend - Rs 1.50 Per Share 1.5000 —
19 Jul 2018 Annual General Meeting/Dividend- Rs 1.50 Per Share 1.5000 —
17 Jul 2017 Annual General Meeting/Dividend - Rs 1.50 Per Share 1.5000 —
15 Sep 2015 Annual General Meeting/ Dividend - Rs 1.25/- Per Share 1.2500 —
15 Sep 2014 Annual General Meeting / Dividend - Re 1/- Per Share 1.0000 —
2 Sep 2013 Annual General Meeting / Dividend Re 0.75/- Per Share 0.7500 —

Corporate Actions

Full history (16 events) →

Bonuses, splits, buybacks and other events. Dividends are listed separately above.

Ex-dateTypeSubject
4 Jul 2025RIGHTSRights 1:7 @ Premium Rs 880/-
23 Jul 2024OTHERAnnual General Meeting
20 Jul 2016OTHER Annual General Meeting

All corporate actions →

Quarterly results, AGMs, buybacks and other board-approved business.

DatePurposeResults
31 Jul 2026 Financial Results Yes
27 Apr 2026 Financial Results Yes
30 Jan 2026 Financial Results Yes
29 Oct 2025 Financial Results Yes
28 Jul 2025 Financial Results Yes

Corporate Announcements

All 876 announcements, with search →

Exchange disclosures (NSE and BSE), most recent first.

DateCategoryAnnouncement
1 Oct 2026 Company Update Astec Lifesciences Ltd - 533138 - Response To Volume Movement Letter
1 Oct 2026 Company Update Astec Lifesciences Ltd - 533138 - Clarification sought from Astec Lifesciences Ltd
1 Oct 2026 Spurt in Volume Significant increase in volume has been observed in Astec LifeSciences Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, had written to the company. Astec LifeSciences Limited has submitted their response.
30 Sep 2026 Spurt in Volume Significant increase in volume has been observed in Astec LifeSciences Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, has written to the company. The response from the company is awaited.
28 Sep 2026 Insider Trading / SAST Astec Lifesciences Ltd - 533138 - Closure of Trading Window
28 Sep 2026 Trading Window Astec LifeSciences Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
18 Sep 2026 Company Update Astec Lifesciences Ltd - 533138 - Response To BSE Query Dated 18.09.2026
18 Sep 2026 Company Update Astec Lifesciences Ltd - 533138 - Clarification sought from Astec Lifesciences Ltd
18 Sep 2026 Spurt in Volume Significant increase in volume has been observed in Astec LifeSciences Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, had written to the company. Astec LifeSciences Limited has submitted their response.
17 Sep 2026 Spurt in Volume Significant increase in volume has been observed in Astec LifeSciences Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, has written to the company. The response from the company is awaited.

All announcements →

SWOT

Tradinity's own rule-based read of the real ratios elsewhere on this page -- not a copy of any third party's, and never a forward-looking prediction.

Strengths

Data unavailable.

Weaknesses

  • Low Return on Equity (-20.7%)
  • Thin net profit margin (-12.6%)
  • High financial leverage (Debt/Equity 1.15)
  • Tight liquidity (Current Ratio 0.89)
  • Declining revenue YoY (-8.3%)

Opportunities

Data unavailable.

Threats

  • Weak interest coverage (-1.1x) -- limited cushion against rising rates

Data unavailable (no single-stock futures or options activity on record for this company).

Frequently asked questions about Astec LifeSciences Limited

Where is the share price?

The price at the top of this page is the last traded price from exchange data; during market hours it refreshes on its own. The Chart & Technicals section has the full price history.

Where are the financial results?

The Financials page has quarterly and annual results, ratios, cash flow and the balance sheet, on a standalone or consolidated basis.

Who owns the company?

The Ownership section shows the latest shareholding pattern from exchange filings, with promoter, FII, DII and public holdings by quarter.

Does Tradinity give buy or sell advice?

No. The scores and checklist on this page are rule-based summaries of published figures, not recommendations. Tradinity is not a registered investment adviser.